7JVQ: Apomorphine-bound dopamine receptor 1
Cryo-EM structure of apomorphine-bound dopamine receptor 1 in complex with Gs protein. Determined by electron microscopy at 3.0 Å resolution. Released 24 Feb 2021.
- Method
- Electron microscopy
- Resolution
- 3.0 Å
- Organisms
- Homo sapiens, synthetic construct
- Chains
- 5
- Atoms
- 8,485
- Mol. weight
- 149.04 kDa
- Ligands
- OR9, CLR, PLM
- Released
- 24 Feb 2021
Explore 7JVQ in 3D
Show helices and sheets
RCSB PDB
PDBe
Secondary structure: helices and β-sheets
7JVQ contains 31 α-helices and 46 β-strands across 5 chains. Residue ranges use author residue numbering, as in the PDB file, from PDBe. To see them in 3D, choose the Cartoon representation with Secondary structure coloring: helices, sheets and coils get different colors.
Chain A: 9 helices, 7 β-strands
| Element | Residues | Length | Sheet |
|---|
| α-helix | 10-39 | 30 | |
| β-strand | 41-47 | 7 | 1 |
| β-strand | 64-65 | 2 | 1 |
| β-strand | 69-75 | 7 | 1 |
| β-strand | 80-86 | 7 | 1 |
| α-helix | 97-102 | 6 | |
| β-strand | 105-111 | 7 | 1 |
| α-helix | 116-129 | 14 | |
| β-strand | 138-144 | 7 | 1 |
| α-helix | 146-153 | 8 | |
| α-helix | 159-163 | 5 | |
| α-helix | 165-168 | 4 | |
| α-helix | 178-179 | 2 | |
| α-helix | 184-204 | 21 | |
| β-strand | 211-215 | 5 | 1 |
| α-helix | 223-242 | 20 | |
Chain B: 5 helices, 28 β-strands
| Element | Residues | Length | Sheet |
|---|
| α-helix | 4-25 | 22 | |
| α-helix | 30-33 | 4 | |
| α-helix | 34-36 | 3 | |
| β-strand | 47-51 | 5 | 2 |
| β-strand | 58-62 | 5 | 3 |
| β-strand | 69-74 | 6 | 3 |
| β-strand | 78-83 | 6 | 3 |
| β-strand | 89-94 | 6 | 3 |
| β-strand | 103-105 | 3 | 4 |
| β-strand | 111-114 | 4 | 4 |
| β-strand | 121-125 | 5 | 4 |
| β-strand | 134-139 | 6 | 4 |
| α-helix | 145 | 1 | |
| β-strand | 146-151 | 6 | 5 |
| β-strand | 156-161 | 6 | 5 |
| β-strand | 166-170 | 5 | 5 |
| β-strand | 176-180 | 5 | 5 |
| α-helix | 186-187 | 2 | |
| β-strand | 189-192 | 4 | 6 |
| β-strand | 198-202 | 5 | 6 |
| β-strand | 208-212 | 5 | 6 |
| β-strand | 218-222 | 5 | 6 |
| β-strand | 229-234 | 6 | 7 |
| β-strand | 240-245 | 6 | 7 |
| β-strand | 249-254 | 6 | 7 |
| β-strand | 260-265 | 6 | 7 |
| β-strand | 273-278 | 6 | 8 |
| β-strand | 284-289 | 6 | 8 |
| β-strand | 294-298 | 5 | 8 |
| β-strand | 304-308 | 5 | 8 |
| β-strand | 315-320 | 6 | 2 |
| β-strand | 327-331 | 5 | 2 |
| β-strand | 336-339 | 4 | 2 |
Chain G: 2 helices, 0 β-strands
| Element | Residues | Length | Sheet |
|---|
| α-helix | 7-23 | 17 | |
| α-helix | 30-43 | 14 | |
Chain N: 2 helices, 11 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 3-7 | 5 | 9 |
| β-strand | 10-12 | 3 | 10 |
| β-strand | 17-25 | 9 | 9 |
| α-helix | 29-31 | 3 | |
| β-strand | 34-39 | 6 | 10 |
| β-strand | 45-51 | 7 | 10 |
| β-strand | 58-60 | 3 | 10 |
| α-helix | 62-64 | 3 | |
| β-strand | 68-73 | 6 | 9 |
| β-strand | 78-84 | 7 | 9 |
| β-strand | 92-98 | 7 | 10 |
| β-strand | 118 | 1 | 10 |
| β-strand | 122-126 | 5 | 10 |
Chain R: 13 helices, 0 β-strands
| Element | Residues | Length | Sheet |
|---|
| α-helix | 22-50 | 29 | |
| α-helix | 53-56 | 4 | |
| α-helix | 60-76 | 17 | |
| α-helix | 78-87 | 10 | |
| α-helix | 95-126 | 32 | |
| α-helix | 130-134 | 5 | |
| α-helix | 137-161 | 25 | |
| α-helix | 192-199 | 8 | |
| α-helix | 200-204 | 5 | |
| α-helix | 205-241 | 37 | |
| α-helix | 265-297 | 33 | |
| α-helix | 310-330 | 21 | |
| α-helix | 335-345 | 11 | |
Molecules and chains
| Molecule | Chains | Type | Length | Organism | UniProt |
|---|
| D(1A) dopamine receptor | R | protein | 502 | Homo sapiens | P21728 (AlphaFold model) |
| Engineered mini-Gi protein alpha sub-unit | A | protein | 246 | Homo sapiens | P63092 (AlphaFold model) |
| Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | B | protein | 354 | Homo sapiens | P62873 (AlphaFold model) |
| Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 | G | protein | 67 | Homo sapiens | P59768 (AlphaFold model) |
| Nanobody35 | N | protein | 135 | synthetic construct | |
Sequence of entity 1 (R), FASTA
>7JVQ_1 D(1A) dopamine receptor (chains R)
DYKDDDDVDMGQPGNGSAFLLAPNGSHAPDHDVTQQRDEENLYFQGASMRTLNTSAMDGT
GLVVERDFSVRILTACFLSLLILSTLLGNTLVCAAVIRFRHLRSKVTNFFVISLAVSDLL
VAVLVMPWKAVAEIAGFWPFGSFCNIWVAFDIMCSTASILNLCVISVDRYWAISSPFRYE
RKMTPKAAFILISVAWTLSVLISFIPVQLSWHKAKPTSPSDGNATSLAETIDNCDSSLSR
TYAISSSVISFYIPVAIMIVTYTRIYRIAQKQIRRIAALERAAVHAKNCQTTTGNGKPVE
CSQPESSFKMSFKRETKVLKTLSVIMGVFVCCWLPFFILNCILPFCGSGETQPFCIDSNT
FDVFVWFGWANSSLNPIIYAFNADFRKAFSTLLGCYRLCPATNNAIETVSINNNGAAMFS
SHHEPRGSISKECNLVYLIPHAVGSSEDLKKEEAAGIARPLEKLSPALSVILDYDTDVSL
EKIQPITQNGQHPTHHHHHHHH
Sequence of entity 2 (A), FASTA
>7JVQ_2 Engineered mini-Gi protein alpha sub-unit (chains A)
MGCLGNSKTEDQRNEEKAQREANKMIEKQLQKDKQVYRATHRLLLLGADNSGKSTIVKQM
RIYHVNSGIFETKFQVDKVNFHMFDVGAQRDERRKWIQCFNDVTAIIFVVDSSDYNRLQE
ALNDFKSIWNNRWLRTISVILFLNKQDLLAEKVLAGKSKIEDYFPEFARYTTPEDATPEP
GEDPRVTRAKYFIRDEFLRISTASGDGRHYCYPHFTCSVDTENARRIFNDCRDIIQRMHL
RQYELL
Sequence of entity 3 (B), FASTA
>7JVQ_3 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (chains B)
HHHHHHHHMGSLLQSELDQLRQEAEQLKNQIRDARKACADATLSQITNNIDPVGRIQMRT
RRTLRGHLAKIYAMHWGTDSRLLVSASQDGKLIIWDSYTTNKVHAIPLRSSWVMTCAYAP
SGNYVACGGLDNICSIYNLKTREGNVRVSRELAGHTGYLSCCRFLDDNQIVTSSGDTTCA
LWDIETGQQTTTFTGHTGDVMSLSLAPDTRLFVSGACDASAKLWDVREGMCRQTFTGHES
DINAICFFPNGNAFATGSDDATCRLFDLRADQELMTYSHDNIICGITSVSFSKSGRLLLA
GYDDFNCNVWDALKADRAGVLAGHDNRVSCLGVTDDGMAVATGSWDSFLKIWNG
Sequence of entity 4 (G), FASTA
>7JVQ_4 Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 (chains G)
ASNNTASIAQARKLVEQLKMEANIDRIKVSKAAADLMAYCEAHAKEDPLLTPVPASENPF
REKKFFC
Sequence of entity 5 (N), FASTA
>7JVQ_5 Nanobody35 (chains N)
MQVQLQESGGGLVQPGGSLRLSCAASGFTFSNYKMNWVRQAPGKGLEWVSDISQSGASIS
YTGSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCARCPAPFTRDCFDVTSTTYAYRG
QGTQVTVSSHHHHHH
Ligands and cofactors
| ID | Name | Formula | Copies |
|---|
| OR9 | (6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol | C17 H17 N O2 | 1 |
| CLR | Cholesterol | C27 H46 O | 5 |
| PLM | Palmitic acid | C16 H32 O2 | 3 |
Primary citation
Structural insights into the human D1 and D2 dopamine receptor signaling complexes. Zhuang, Y., Xu, P., Mao, C. et al. Cell (2021) 184:931-942.e18. DOI 10.1016/j.cell.2021.01.027 · PubMed
Other PDB entries of the same protein (UniProt P21728 (AlphaFold model), which also has an AlphaFold model), best resolution first:
- 9WG6 2.44 Å, D1R-Gs in complexed with Dopamine/LY3154207/BMSA1/UNC9815
- 9WG0 2.59 Å, D1R-Gs in complexed with SKF81297/LY3154207/BMSA1/UNC10062
- 9LLJ 2.61 Å, Cryo-EM structure of D1R-Gs in complex with de novo designed GEM targetingTM1/2/4 and…
- 9LLF 2.64 Å, Cryo-EM structure of D1R-Gs in complex with de novo designed GEM targeting TM3/4/5
- 9WEU 2.65 Å, D1R-Gs in complexed with SKF81297/LY3154207/BMSA1
- 9I54 2.72 Å, Dopamine 1 receptor:GaS complex bound to 24
- 9LLH 2.73 Å, Cryo-EM structure of D1R-Gs in complex with de novo designed agonist-positive allosteric…
- 9LLG 2.77 Å, Cryo-EM structure of D1R in complex with de novo designed negative allosteric GEM…
- 9I52 2.8 Å, Dopamine 1 receptor:GaS complex bound to 19B
- 7JVP 2.9 Å, Cryo-EM structure of SKF-83959-bound dopamine receptor 1 in complex with Gs protein
- 9LLE 2.9 Å, Cryo-EM structure of D1R-Gs in complex with de novo designed GEM targeting TM1/2/4
- 9LWC 2.9 Å, Cryo-EM structure of epinephrine bound dopamine receptor 1…
Browse structure collections
About this viewer
MolViewer shows 7JVQ directly in your browser with nothing to install. Switch between cartoon, ball-and-stick, spacefill and surface views, color by chain, secondary structure or B-factor, measure distances, angles and dihedrals, and share or embed the view.